Inspire Medical Systems, Inc. $INSP Shares Acquired by Eventide Asset Management LLC

Eventide Asset Management LLC lifted its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 71.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 440,205 shares of the company’s stock after purchasing an additional 183,547 shares during the quarter. Eventide Asset Management LLC owned 1.51% of Inspire Medical Systems worth $40,601,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in INSP. CWM LLC grew its stake in shares of Inspire Medical Systems by 216.1% during the 4th quarter. CWM LLC now owns 354 shares of the company’s stock worth $33,000 after purchasing an additional 242 shares during the period. Havemeyer Place LP acquired a new stake in shares of Inspire Medical Systems during the 4th quarter worth approximately $39,000. V Square Quantitative Management LLC acquired a new stake in shares of Inspire Medical Systems during the 4th quarter worth approximately $40,000. Smartleaf Asset Management LLC grew its stake in shares of Inspire Medical Systems by 84.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock worth $42,000 after purchasing an additional 205 shares during the period. Finally, Larson Financial Group LLC grew its stake in shares of Inspire Medical Systems by 21,266.7% during the 3rd quarter. Larson Financial Group LLC now owns 641 shares of the company’s stock worth $48,000 after purchasing an additional 638 shares during the period. Institutional investors and hedge funds own 94.91% of the company’s stock.

Inspire Medical Systems Stock Performance

Shares of NYSE INSP opened at $42.74 on Friday. The firm has a market cap of $1.23 billion, a PE ratio of 9.52, a PEG ratio of 4.41 and a beta of 0.73. The firm has a fifty day moving average of $48.05 and a 200 day moving average of $71.79. Inspire Medical Systems, Inc. has a one year low of $38.91 and a one year high of $147.03.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, May 4th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of ($0.28) by $0.38. The company had revenue of $204.58 million during the quarter, compared to analyst estimates of $200.04 million. Inspire Medical Systems had a net margin of 14.33% and a return on equity of 10.35%. The firm’s revenue was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.10 EPS. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. On average, equities analysts predict that Inspire Medical Systems, Inc. will post 0.91 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on INSP. Bank of America cut shares of Inspire Medical Systems from a “neutral” rating to an “underperform” rating and set a $39.00 price objective on the stock. in a research note on Friday, May 22nd. Mizuho dropped their price target on shares of Inspire Medical Systems from $70.00 to $55.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 5th. Zacks Research lowered shares of Inspire Medical Systems from a “hold” rating to a “strong sell” rating in a report on Wednesday, May 13th. Truist Financial cut their price target on shares of Inspire Medical Systems from $64.00 to $50.00 and set a “hold” rating for the company in a report on Tuesday, May 5th. Finally, Evercore set a $55.00 price target on shares of Inspire Medical Systems in a report on Tuesday, May 5th. Four analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $81.84.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.